相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails
Zoe R. Ash et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature
Elena Bartoloni et al.
AUTOIMMUNITY REVIEWS (2012)
Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): New biomarkers in ankylosing spondylitis
Nora Bodnar et al.
JOINT BONE SPINE (2012)
Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies
F. Pratesi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Stratification by age of onset with 30 years as age limit is an effective means of identifying PSORS1-associated psoriasis in patients with psoriatic arthritis
Ruben Queiro et al.
JOINT BONE SPINE (2011)
Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis
L. Damjanovska et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis
Andrea Tesija-Kuna et al.
CLINICAL RHEUMATOLOGY (2010)
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
G. Wells et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis
J. T. Elder
GENES AND IMMUNITY (2009)
Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease
D. McGonagle
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis
Ernst Wagner et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Antibodies to citrullinated proteins in arthritis:: pathology and promise
Lars Klareskog et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
Annette H. M. van der Helm-van Mil et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Pascale Nicaise Roland et al.
ARTHRITIS RESEARCH & THERAPY (2008)
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci
Ying Liu et al.
PLOS GENETICS (2008)
Antibodies against citrullinated vimentin in rheumatoid arthritis
Linda Mathsson et al.
ARTHRITIS AND RHEUMATISM (2008)
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
Holger Bang et al.
ARTHRITIS AND RHEUMATISM (2007)
High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor a inhibitors in rheumatoid arthritis
Francesca Bobbio-Pallavicini et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
HA Chen et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment
P Caramaschi et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Genetic epidemiology of psoriasis and psoriatic arthritis
P Rahman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
L De Rycke et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
B Vander Cruyssen et al.
AUTOIMMUNITY REVIEWS (2005)
Does a positive anti-CCP test identify a distinct arthritis entity?
T Skogh
ARTHRITIS RESEARCH & THERAPY (2005)
Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome
JE Gottenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
C Alessandri et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
ER Vossenaar et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Assessment of patients with psoriatic arthritis - A review of currently available measures
DD Gladman et al.
ARTHRITIS AND RHEUMATISM (2004)
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
S Rantapää-Dahlqvist et al.
ARTHRITIS AND RHEUMATISM (2003)
Clinical utility of the anti-CCP assay in patients with rheumatic diseases
DM Lee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis
J Vencovsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
T Avcin et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
How to diagnose rheumatoid arthritis early - A prediction model for persistent (erosive) arthritis
H Visser et al.
ARTHRITIS AND RHEUMATISM (2002)
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value
MAM van Boekel et al.
ARTHRITIS RESEARCH (2002)
Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis
R Mediwake et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Insights into rheumatoid arthritis derived from the Sa immune system
HA Menard et al.
ARTHRITIS RESEARCH (2000)
分享论文
